Discussion page for Arch Therapeutics (ARTH)

By Lynn Clark, Stock Gumshoe, November 6, 2017

This page is for discussion of Arch Therapeutics (ARTH).

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

692
Share your thoughts...

avatar
169 Comment threads
523 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
130 Comment authors
toddbaGriffinfrankw17dunnydamejoevan30000 Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

dan62
Irregular
πŸ‘207

Tick tock, tick tock.. The clock..

jumboh
Member
πŸ‘131
jumboh

$arth np

Looks like some heartburn for shareholders today

mosley1234
Member
πŸ‘552

ARTH
What takes so long for the FDA to respond to their NDA, they did submit one.

Add a Topic
3022
richardo8586
Member
πŸ‘510
richardo8586

Frustrated as well.

jumboh
Member
πŸ‘131
jumboh

$arth

on average it takes about 6 months. Its been 4.5 or so.

lukystrike
Member
πŸ‘2
lukystrike

I have a question about the FDA 510k approval. I see the following from the FDA website regarding device registration and ARTH is listed in their database now as per the link below. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=529643&lpcd=NAE Initial Registration Submit registration and /or listing information within 30 days of an establishment beginning an activity or putting a device into commercial distribution. Foreign establishments must register before exporting products to the United States and domestic importers must register before importing products. Reminder that if your device requires premarket notification clearance or approval, you will have to wait until your premarket submission [510(k), PMA, etc.]… Read More Β»

Add a Topic
3022
Add a Topic
3022
JohnM
Irregular
πŸ‘1978

This was posted on the main discussion thread: Author: watermaven Comment: $ARTH np. I recently said I would try to contact the FDA to see if the designation β€œ510K-exempt” showing on Arch Therapeutics application was an error, as I believe Dr. Norchi said he thought it was β€œodd” or something to that effect, when the Gummies asked, and some Gummies said they did not understand it. In speaking with a project director in the department that is handling this application I could only get general information as they have to be very careful to not disclose details to anyone not… Read More Β»

Add a Topic
3022
Add a Topic
3022
Add a Topic
3022
mtpoulsen
Irregular
πŸ‘2183
codaras
Member
πŸ‘115
codaras

$ARTH long. Nice find. Makes me think of Arch also. Guessing they have external approval even before this could apply.

finventurer
Irregular
πŸ‘319
finventurer

Bravo Marianne, thank you for this! at least maybe some good news for Arch Therapeutics πŸ˜‰

billywade88
Member
πŸ‘123
billywade88

Hey y’all, I don’t normally post I just lurk a lot, LOL. I have been heavily into Arch Therapeutics since it was $0.19 a share. This business has been covered extensively in the threads, both on the main thread and on the old Arch Therapeutics thread that has since been closed. I’m not telling you not to do your due diligence—that is something that all investors should do. What I will say is that there is no product to compare AC5 to. It is unique and revolutionary. The good doctor has researched the technology involved thoroughly, and met with the… Read More Β»

toddba
Member
πŸ‘1152
toddba

Well said

mobilecc
Member
πŸ‘76

Does anyone know what happened to the price on Tuesday 11/7 when it took a dive from .72 to .48 and bounced back within hours? Who dumped a large position and why? Profit taking? Or is there some news coming? Perhaps an unsolvable mystery but somebody knows the answer

TomN
Irregular
πŸ‘355
TomN

$ARTH- Mobilecc.. there’s a string of comments on the main thread..
https://www.stockgumshoe.com/2017/10/tear-sheet-cohbar-industries-cwbr/comment-page-12/#comment-4958724

rusty15
Member
πŸ‘308

$arth long. 5k traded pre-market. Almost never see that. That precisely orchestrated stop grab the other day, pretty decent volume yesterday…people are getting antsy waiting for news…

Lannas
Member
πŸ‘851
Lannas

OTC stocks do not trade pre – post market hours. What you see are late trade settlements.
https://www.timothysykes.com/blog/do-otcbb-and-pink-sheet-penny-stocks-trade-premarket-or-afterhours-video-answer/

dan62
Irregular
πŸ‘207

$ARTH
Im going to buy a. Condo in a town that is fun. I want to walk out go get breakfast maybe a snort..I’m tired of living the American drive lifestyle.. I started out working on high voltage.. Now doing security for those same systems.. What a strange crazy ride it’s been.. 38 years worth..Just need them to execute..

dan62
Irregular
πŸ‘207

I have $HLMIX in my defined pension. These guys are up like 28% ytd if you want some international exposure.. GLTA

dunnydame
Member
πŸ‘996
dunnydame

#pipe dreams
Check out downtown Denver, CO – but $ARTH will need to rocket to a much larger price to be able to do it. (Or maybe you have a Very Large position?) (No need to tell me.)
$ARTH ow

petervr
Irregular
πŸ‘1537
petervr

$ no investment value
A Fascinating Brain.
A most readable and interesting story from the NY Times
http://tinyurl.com/ybjv2muk

finventurer
Irregular
πŸ‘319
finventurer

Arch Therapeutics 10-K: Our long-term business plan includes the following goals: Β· conducting required biocompatibility studies and additional clinical trials on AC5 and related products; Β· expanding and maintaining protection of our intellectual property portfolio; Β· developing appropriate third party relationships to manufacture, distribute, market and otherwise commercialize AC5; Β· obtaining regulatory approval or certification of AC5 and related products in the EU, the U.S., and other jurisdictions as we may determine; Β· continuing or developing academic, scientific and institutional relationships to collaborate on product research and development; and Β· developing additional product candidates in the hemostatic, sealant, and/or other… Read More Β»

Add a Topic
3022
Add a Topic
3022
finventurer
Irregular
πŸ‘319
finventurer

everything seems to be proceeding accordingly – at least i didn’t find anything suspicious or outright wrong in latest 10-K. holding onto my atlas position of $ARTH and waiting for positive FDA results.

Add a Topic
3022
swgoombah
Member
πŸ‘410
swgoombah

Deleted by poster, wrong forum!

finventurer
Irregular
πŸ‘319
finventurer

wow! i wonder what’s happening there? πŸ˜›

dunnydame
Member
πŸ‘996
dunnydame

#CHFS (deleted)
According to Schwab’s charts, the share price was $576 a year ago!

swgoombah
Member
πŸ‘410
swgoombah

$CHFS The chart is crazy. Kick it back to the 3 year and it was almost $3500. Crazy low float but 9.1 mil volume today.

dunnydame
Member
πŸ‘996
dunnydame

$CHFS Even crazier – they performed a 1:20 reverse stock split on 10/13/17. And the high point 4 years ago was $8280. There’s probably a reason, but on the face of it, it’s bizarre. Somewhere in all this there’s a change of name too.
OK back to ARTH. Sorry for going off-topic.
$ARTH ow

Add a Topic
5971
rvh_investing
Irregular
πŸ‘10
rvh_investing

$arth could be the start of a monster run

richardo8586
Member
πŸ‘510
richardo8586

Which way?

finventurer
Irregular
πŸ‘319
finventurer

$ARTH atlas OW I’ve been wondering if anybody else here is still holding onto their Arch Therapeutics shares full of confidence that this year will bring about change. There was a lot of discussion about Arch in Dr. KSS main thread near new year, but soon after discussion has withered. I remember quite many telling they’ve sold their share in lack on confidence on CEO Norchi and way company seems to be trembling into every single crack infront of them Correct me if i’m wrong, but i remember Dr. KSS mentioning 510(k) approval wouldn’t have been such a big deal… Read More Β»

Add a Topic
4393
MarshallDillion
Irregular
πŸ‘76
MarshallDillion

$ARTH fp. Yes still holding knowing that we may have wait likely until the end of 2018, if not into 2019 for any meaningful catalyst. It may be very possible that the 510k may not get resubmitted until the internal use of AC5 is completed. This depends on the nature of the questions the FDA asked. DR. KSS did mention the possibility that the questions the FDA wants answered may be related to AC5 safety or durability inside tissues rather than as just an external dressing. This would mean you would have to do some internal use testing which is… Read More Β»

Add a Topic
4393
JohnM
Irregular
πŸ‘1978

$ARTH ow, With all respect, I believe you are very wrong. Look at slide 21 of the Biotech Showcase presentation. Norchi, who knows what the FDA asked for, plans to resubmit the 510(k) as well as file the IDE for internal use, as well as file for the CE Mark – all in 2018. Also, the peer-reviewed paper on the clinical trial is imminent (slide 5).

Add a Topic
4393
achandra13
Member
πŸ‘2028
achandra13

$ARTH Thanks for clearing that up JohnM. I am not touching my ARTH shares for a long time. I have been through at least two similar periods of uncertainty and and dip in price and in the end they turned out to be nothing. This is a small company and people need to be practical and give them time to grow. Look how far they have come in the last two years while burning so little money compared to any other biotech company. If you are looking for blazzing fast gains, ARTH will really disappoint you as it is and… Read More Β»

Add a Topic
4393
dunnydame
Member
πŸ‘996
dunnydame

#Greenrider – $ARTH durability after surgery
If this question wasn’t answered already, they’d probably do the research on animals so there’s be no moral problem with opening up the wound again (except for making my animal-loving heart cringe). But I could be all wrong, and I won’t be offended if anyone corrects me.
Cheers,
Penny

Add a Topic
6225
pgathua
Member
πŸ‘683
pgathua

$ARTH Np for anyone planning to buy ARTH , now is the time to do it with the stock at 0.45 cents…not scrambling when returns to $0.80 cents

Add a Topic
5971
simong156
Member
πŸ‘321
simong156

$ARTH Whilst the science is strong, the financials resonable (and it would be interesting for Cleveland’s latest take), we have management issues. Fatal? I bet not, but would my shares be better in APTO – probably. However, it’s been a good few years in Arch and whilst two of the three are class leading and one “pillar” is weak I feel inclined to hold as much through inertia as anything else. But it is so frustrating and Norchi attacking Dr KSS was unpalatable. If it were in an account without tax implications I’d likely reduce significantly.

Add a Topic
3932
ray D
Irregular
πŸ‘51
ray D

$ARTH I missed where Norchi attacked DR KSS. I didn’t see that in the threads. Was that on twitter?

Add a Topic
3932
ajgormican
Member
πŸ‘338
ajgormican

I think what was said is that TN was frustrated with KSS because someone from the group was trying to get some answers to some questions. KSS, I believe, felt he had no right to blame KSS for anything. Im still long, Im not willing to sell underwater over an emotional reaction. I hope it recovers sooner than later, and then I myself might consider getting out, because I believe they may need to raise funds this year at some point.

ray D
Irregular
πŸ‘51
ray D

Thanks for your response. I have thought they would need to raise money too. I have also wondered if the information the FDA is requesting is going to require another trial.

Add a Topic
3022
ajgormican
Member
πŸ‘338
ajgormican

good question?

petervr
Irregular
πŸ‘1537
petervr

$ Tickers
ray D – would you please include $ Tickers with your posts, so that people following on e-mail will have some idea of who or what you are referring to. Thanks.

ray D
Irregular
πŸ‘51
ray D

$ ticker Apologies, I didn’t realize people couldn’t see the thread title either.

JohnM
Irregular
πŸ‘1978

ray D, we email followers can see the thread title, no problem.

paulcarey
Member
πŸ‘30
paulcarey

ARTH. I wonder if TN is regretting his accusatory conversation with Dr KSS AND if he maybe now has a better appreciation of the SG investing group? I just wished that I had acted on what appeared to be a β€œcooling off’ on ARTH by Dr KSS and Cleveland, prior to the more formal acknowledgement; not based on science but the lack of execution.
I always try to learn from my mistakes and I will learn from this one.

Add a Topic
3932
Add a Topic
3932
tanglewood
Irregular
πŸ‘446

ray D re;$ARTH Norchi was upset that Ron Oliver in our group contacted Elaine Whitmore. She should have been told by Norchi not to release insider information. Here is what started it all.
https://www.stockgumshoe.com/2018/01/the-twelve-biotechs-of-christmas-2018-balthasar/comment-page-4/#comment-4969480

JohnM
Irregular
πŸ‘1978

She almost certainly WAS told by Norchi not to talk to anyone. Norchi’s anger should have been directed at her, not DR KSS – as I suspect he has figured out now that the stock has been taken to the woodshed.

Add a Topic
3932
Add a Topic
5971
rumrunner
Member
πŸ‘-141
rumrunner

$ARTH There were other conversations subsequent to Ron Olivers. I believe it was the one involving the FDA that TN had a problem with.

Read ARTH yahoo Conversations to obtain a much broader prospective of the situation, This blog limits counter views.

Add a Topic
3022
mary
Member
πŸ‘792
mary

$ARTH….Not on twitter….in the same comment from Dr KSS where he stated he had sold all arth. I have lost all confidence in TN….there is no reason why he should have been angry at DR KSS because someone else in our group called and asked questions…DR KSS has always encouraged us to call companies ourselves when we have questions but evidently TN was miffed; makes me think things are not well with arth. I continue to hold all my arth shares at this time hoping for a better price in a few months or next year even. Already major overweight… Read More Β»

Add a Topic
3932
Add a Topic
3932
gunstar50
Member
πŸ‘62

I sold a lot of mine as well. I was severely overweight. Definitely lost on this one. That being said I would never blame Dr. Kss or anyone else on this board. I have always wondered why a company with such brilliant science hasn’t been bought out or why it takes so long for them to get anything done. It just doesn’t make sense. I hope that Dr. Kss returns. He takes time out of his day to help us all better understand the science behind so many biotech stocks. I for one have always been grateful for his vast… Read More Β»

Add a Topic
3932
Add a Topic
3932
SoGiAm
Member
πŸ‘11385

#Billionaie Tolga > I can’t harp on anymore about quality management. It’s understandable if things go wrong and you work towards rebuilding. To not be transparent is not acceptable. https://twitter.com/KumovaTolga/status/956055192524517376 Best2ALL

SoGiAm
Member
πŸ‘11385

$ONCS reduced to skeletal 20180124 –
When the geauxing gets tough, the tough get geauxing….

$ARTH ow, $INO sp – Inclined 2 reduction – #TerryNorchi, #AvtarDhillon https://www.marketwatch.com/investing/stock/ino/insiders?pid=69647, #Cleveland and staffs nerd to nut up and come clean or reap the consequences of non-transparency! Feeling played by self-serving professionals. Absence certainly does NOT make this heart grow founder, in this situation. imho #DYODDNIAIA

Dueling Banjos https://www.youtube.com/watch?v=A8rUZfQJjPY πŸ™‚

Add a Topic
5960
Add a Topic
4393
Add a Topic
5189